Literature DB >> 3783447

A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity.

M S Roberts, M Rowland.   

Abstract

The dispersion model of hepatic elimination is based on the distribution of residence times of blood elements within the liver. The model has two asymptotic solutions corresponding to the "well-stirred" model (complete mixing of blood elements) and the "parallel-tube" model (no variation in residence times of blood elements). The steady-state form of the dispersion model relevant to pharmacokinetic analysis is developed and explored with respect to changes in blood flow, in binding within blood, and in hepatocellular enzyme activity. Literature data are used to evaluate discrepancies among the predictions of the dispersion, well-stirred, and tube models. It is concluded that the dispersion model is consistent with the data. The limitations of steady-state perfusion experiments to estimate the residence time distribution of blood elements within the liver are considered.

Mesh:

Substances:

Year:  1986        PMID: 3783447     DOI: 10.1007/bf01106707

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  49 in total

1.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

2.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

Review 3.  Factors regulating drug metabolism in intact hepatocytes.

Authors:  R G Thurman; F C Kauffman
Journal:  Pharmacol Rev       Date:  1979-12       Impact factor: 25.468

4.  Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models.

Authors:  A B Ahmad; P N Bennett; M Rowland
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

5.  The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog.

Authors:  T L Whitsett; P G Dayton; J L McNay
Journal:  J Pharmacol Exp Ther       Date:  1971-04       Impact factor: 4.030

6.  Albumin binding and hepatic uptake: the importance of model selection.

Authors:  E L Forker; B A Luxon
Journal:  J Pharm Sci       Date:  1983-10       Impact factor: 3.534

7.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

8.  Use of unbound drug concentration in blood to discriminate between two models of hepatic drug elimination.

Authors:  D J Morgan; K Raymond
Journal:  J Pharm Sci       Date:  1982-05       Impact factor: 3.534

Review 9.  Functional implications of liver cell heterogeneity.

Authors:  J J Gumucio; D L Miller
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

10.  Flow dependence of first-order uptake of substances by heterogeneous perfused organs.

Authors:  L Bass
Journal:  J Theor Biol       Date:  1980-09-21       Impact factor: 2.691

View more
  34 in total

1.  An isolated in-situ rat head perfusion model for pharmacokinetic studies.

Authors:  K A Foster; G D Mellick; M Weiss; M S Roberts
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

3.  Optimal experimental design for precise estimation of the parameters of the axial dispersion model of hepatic elimination.

Authors:  C H Chou; L Aarons; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-10

4.  Founding figures of pharmacokinetics: tribute to Malcolm Rowland.

Authors:  Leon Aarons; Leslie Z Benet
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-12       Impact factor: 2.745

5.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

Review 6.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

7.  Availability predictions by hepatic elimination models for Michaelis-Menten kinetics.

Authors:  M S Roberts; J D Donaldson; D Jackett
Journal:  J Pharmacokinet Biopharm       Date:  1989-12

8.  A comparative investigation of hepatic clearance models: predictions of metabolite formation and elimination.

Authors:  M V St-Pierre; P I Lee; K S Pang
Journal:  J Pharmacokinet Biopharm       Date:  1992-04

9.  Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.

Authors:  L P Rivory; M S Roberts; S M Pond
Journal:  J Pharmacokinet Biopharm       Date:  1992-02

Review 10.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.